Type 2 Diabetes Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who identify themselves as being of Indian or African ancestry.
- People who were diagnosed with diabetes between the ages of 18 and 47 years old.
- People who have been diagnosed as having type 2 diabetes.
- People who have been hospitalised for a dangerous build-up of acid in the blood related to diabetes (sometimes called diabetic ketoacidosis).
- People who have experienced significant unexplained weight loss — more than 10% of body weight in less than 6 months — without a clear reason.
- People who have a physical appearance suggesting an unusual loss or redistribution of body fat (confirm with trial site).
- People who have a muscle condition (myopathy) or hearing loss (deafness) alongside their diabetes.
- People who developed kidney problems either at the time of their diabetes diagnosis or within 3 years of it.
- People who developed heart problems either at the time of their diabetes diagnosis or within 3 years of it.
- People whose diabetes has responded poorly to non-insulin diabetes treatments despite taking those treatments as directed.
- People who have tested negative for all of the following diabetes-related antibodies: anti-islet (ICA), anti-IA2, anti-insulin, anti-ZnT8, and anti-GAD antibodies.
- People who have signed an informed consent form agreeing to take part in the trial.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have type 1 diabetes.
- People who have tested positive for type 1 diabetes-related antibodies.
- People whose diabetes is caused by another condition, such as a pancreas disease, a hormonal disorder, a medication, or an infection.
- People who have other autoimmune conditions alongside their diabetes.
- People who are pregnant.
- People who do not wish to participate in the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Fritz-Line VELAYOUDOM, Doctor, CHU de la Guadeloupe
Phone: 0590 89 13 00
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
known pathogenic mutations described in monogenic diabetes of the MODY type
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.